{"id":61763,"date":"2025-08-22T19:05:40","date_gmt":"2025-08-22T17:05:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/"},"modified":"2025-08-22T19:05:40","modified_gmt":"2025-08-22T17:05:40","slug":"second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/","title":{"rendered":"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West"},"content":{"rendered":"
\n

\nHuntsman Cancer Institute adds a second compact proton therapy system, strengthening its leadership in the region<\/p>\n

<\/a>
<\/a><\/p>\n

LITTLETON, Mass.–(BUSINESS WIRE)–#ProtonTherapy<\/a>–Mevion Medical Systems today announced that Huntsman Cancer Institute at the University of Utah has signed a contract for a second MEVION S250i Proton Therapy System.<\/p>\n

\nHuntsman is the first and only proton therapy center in the Mountain West and has become a vital resource for patients across Utah, Idaho, Montana, Nevada, and Wyoming. Since opening the Senator Orrin G. Hatch Center for Proton Therapy in 2021, the institute has provided life-changing treatments for both adult and pediatric patients \u2014 with nearly one-third of its proton patients being children.<\/p>\n

\nThe new system will double treatment capacity and broaden access to patients with a wide range of cancers, including pediatric, head and neck, and breast cancers. Huntsman\u2019s expansion ensures patients can receive advanced care close to home, rather than traveling to distant proton centers in Phoenix, Seattle, or San Diego.<\/p>\n

\nThe second system will be the latest-generation MEVION S250i, equipped with HYPERSCAN Pencil Beam Scanning and Adaptive Aperture pMLC, ensuring clinical and operational parity across both rooms. The existing system will also be upgraded to current specifications, so both rooms share the same advanced capabilities.<\/p>\n

\nTina Yu, Ph.D., CEO of Mevion Medical Systems, commented: \u201cMore and more cancer centers are adopting our 1+1 model \u2014 starting with a single system and expanding to two fully capable rooms. This is the most pragmatic and cost-effective approach to proton therapy. The benefits are clear: more patients treated with better economics, 100% uptime, expanded research opportunities, staged upgrades, and the ability to remain at the latest technology level without ever shutting down the center. Huntsman\u2019s decision reinforces this model as the path forward for sustainable proton therapy growth.\u201d<\/p>\n

\nThis second system demonstrates how the MEVION S250i platform enables strategic growth, allowing leading cancer centers to expand seamlessly by building on existing infrastructure and resources. It reflects a model of sustainable capacity expansion that creates a scalable pathway for bringing advanced care closer to patients.<\/p>\n

\nAbout Mevion Medical Systems:
\n
<\/b>Mevion Medical Systems is the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy. Since 2013, Mevion compact proton therapy single-room systems have been used by leading cancer centers for treating patients. Mevion\u2019s series of products, including the flagship MEVION S250i and MEVION S250-FIT* with HYPERSCAN pencil beam scanning, represent the world\u2019s most compact proton therapy systems that eliminate the obstacles of size, complexity, and cost. Mevion is headquartered in Littleton, Massachusetts with a presence in Europe and Asia. For more information, please visit www.mevion.com<\/a>.<\/p>\n

\n*The MEVION S250-FIT Proton Therapy System is not yet available for clinical use.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contacts:<\/p>\n

\nJacqueline Abner-Pongratz
\n
Mevion Medical Systems
\n
Jacqueline.Pongratz@mevion.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Huntsman Cancer Institute adds a second compact proton therapy system, strengthening its leadership in the region LITTLETON, Mass.–(BUSINESS WIRE)–#ProtonTherapy–Mevion Medical Systems today announced that Huntsman Cancer Institute at the University of Utah has signed a contract for a second MEVION S250i Proton Therapy System. Huntsman is the first and only proton therapy center in the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61763","6":"format-standard","7":"category-industry"},"yoast_head":"\nSecond MEVION S250i to Expand Proton Therapy Capacity in the Mountain West - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Huntsman Cancer Institute adds a second compact proton therapy system, strengthening its leadership in the region LITTLETON, Mass.–(BUSINESS WIRE)–#ProtonTherapy–Mevion Medical Systems today announced that Huntsman Cancer Institute at the University of Utah has signed a contract for a second MEVION S250i Proton Therapy System. Huntsman is the first and only proton therapy center in the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-22T17:05:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250822963875\/en\/649039\/22\/MevionLogo-color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West\",\"datePublished\":\"2025-08-22T17:05:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/\"},\"wordCount\":504,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250822963875\\\/en\\\/649039\\\/22\\\/MevionLogo-color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/\",\"name\":\"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250822963875\\\/en\\\/649039\\\/22\\\/MevionLogo-color.jpg\",\"datePublished\":\"2025-08-22T17:05:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250822963875\\\/en\\\/649039\\\/22\\\/MevionLogo-color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250822963875\\\/en\\\/649039\\\/22\\\/MevionLogo-color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/","og_locale":"en_US","og_type":"article","og_title":"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West - Pharma Trend","og_description":"Huntsman Cancer Institute adds a second compact proton therapy system, strengthening its leadership in the region LITTLETON, Mass.–(BUSINESS WIRE)–#ProtonTherapy–Mevion Medical Systems today announced that Huntsman Cancer Institute at the University of Utah has signed a contract for a second MEVION S250i Proton Therapy System. Huntsman is the first and only proton therapy center in the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-22T17:05:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250822963875\/en\/649039\/22\/MevionLogo-color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West","datePublished":"2025-08-22T17:05:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/"},"wordCount":504,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250822963875\/en\/649039\/22\/MevionLogo-color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/","url":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/","name":"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250822963875\/en\/649039\/22\/MevionLogo-color.jpg","datePublished":"2025-08-22T17:05:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250822963875\/en\/649039\/22\/MevionLogo-color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250822963875\/en\/649039\/22\/MevionLogo-color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/second-mevion-s250i-to-expand-proton-therapy-capacity-in-the-mountain-west\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Second MEVION S250i to Expand Proton Therapy Capacity in the Mountain West"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61763"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61763\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}